Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Aloui, Chaker ^a,b   Sut, Caroline ^a   Prigent, Antoine ^a,b   Fagan, Jocelyne ^b   Cognasse, Fabrice ^a,b   Granados Herbepin, Viviana ^c   Touraine, Renaud ^c   Pozzetto, Bruno ^a   Aouni, Mahjoub ^d   Fendri, Chedlia ^d   Hassine, Mohsen ^e   Chakroun, Tahar ^f   Jemni Yacoub, Saloua ^f   Garraud, Olivier ^a,b   Laradi, Sandrine ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c St Etienne University Hospital   (France)

^d UNIVERSITY OF MONASTIR   (Tunisia)

^e FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^f F Hached University Hospital   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; IMMUNOLOGIC FACTOR;

ADULT; ALLELE; BLOOD TRANSFUSION REACTION; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; ALLELES; CD40 LIGAND; FEMALE; GENOTYPE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFUSION REACTION; YOUNG ADULT;

EID: 84935079617     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07239     Document Type: Article

References (67)

1. Horner, A. A., Jabara, H., Ramesh, N. & Geha, R. S. gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes. J Exp Med 181, 1239-44 (1995).
2. Grammer, A. C. et al. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 154, 4996-5010 (1995).
3. Van Kooten, C. & Banchereau, J. CD40-CD40 ligand: a multifunctional receptorligand pair. Adv Immunol 61, 1-77 (1996).
4. Wagner, A. H., Guldenzoph, B., Lienenluke, B. & Hecker, M. CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction. Arterioscler Thromb Vasc Biol 24, 715-20 (2004).
5. Suarez, A., Mozo, L., Gayo, A., Zamorano, J. & Gutierrez, C. Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand. Involvement of transcriptional and posttranscriptional mechanisms. Eur J Immunol 27, 2822-9 (1997).
6. Elgueta, R. et al. Molecularmechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 229, 152-72 (2009).
7. Foy, T. M. et al. Blockade of CD40-CD154 interferes with human T cell engraftment in scid mice. Cell Transplant 7, 25-35 (1998).
8. Korthauer, U. et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539-41 (1993).
9. MacDonald, K. P., Nishioka, Y., Lipsky, P. E. & Thomas, R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 100, 2404-14 (1997).
10. Inoue, S. et al. Enhancement of dendritic cell activation via CD40 ligandexpressing gammadelta T cells is responsible for protective immunity to Plasmodium parasites. Proc Natl Acad Sci U S A 109, 12129-34 (2012).
11. Henn, V. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591-4 (1998).
12. Lindmark, E., Tenno, T. & Siegbahn, A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 20, 2322-8 (2000).
13. Andre, P., Nannizzi-Alaimo, L., Prasad, S. K. & Phillips, D. R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106, 896-9 (2002).
14. Phipps, R. P. et al. The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis. Curr Opin Investig Drugs 2, 773-7 (2001).
15. Jin, Y. et al. Characterization of soluble CD40 ligand released from human activated platelets. J Med Dent Sci 48, 23-7 (2001).
16. Inwald, D. P., McDowall, A., Peters, M. J., Callard, R. E. & Klein, N. J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92, 1041-8 (2003).
17. Langer, H. F. & Chavakis, T. Platelets and neurovascular inflammation. Thromb Haemost 110, 888-93 (2013).
18. Siddiqui, T. I., Kumar, K. S. & Dikshit, D. K. Platelets and atherothrombosis: causes, targets and treatments for thrombosis. Curr Med Chem 20, 2779-97 (2013).
19. Khan, S. Y. et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108, 2455-62 (2006).
20. Blumberg, N., Gettings, K. F., Turner, C., Heal, J. M. & Phipps, R. P. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 46, 1813-21 (2006).
21. Cognasse, F., Payrat, J. M., Corash, L., Osselaer, J. C. & Garraud, O. Platelet components associated with acute transfusion reactions: the role of plateletderived soluble CD40 ligand. Blood 112, 4779-80; author reply 4780-1 (2008).
22. Hamzeh-Cognasse, H. et al. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. Transfusion 54, 613-25 (2014).
23. Nguyen, K. A. et al. A computerized prediction model of hazardous inflammatory platelet transfusion outcomes. PLoS One 9, e97082 (2014).
24. Service, S., International Collaborative Group on Isolated, P., Sabatti, C. & Freimer, N. Tag SNPs chosen from HapMap perform well in several population isolates. Genet Epidemiol 31, 189-94 (2007).
25. Nuchnoi, P. et al. Linkage disequilibrium structure of the 5q31-33 region in a Thai population. J Hum Genet 53, 850-6 (2008).
26. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-5 (2005).
27. Wagner, T. et al. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62, 369-76 (1999).
28. Schonbeck, U., Mach, F. & Libby, P. CD154 (CD40 ligand). Int J Biochem Cell Biol 32, 687-93 (2000).
29. Rigaud, S. et al. Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG. Blood 118, 252-61 (2011).
30. Toure, O. et al. Candidate polymorphisms and severe malaria in a Malian population. PLoS One 7, e43987 (2012).
31. Pineda, B. et al. Gene-gene interaction between CD40 and CD40L reduces bone mineral density and increases osteoporosis risk in women. Osteoporos Int 22, 1451-8 (2011).
32. Malarstig, A., Lindahl, B., Wallentin, L. & Siegbahn, A. Soluble CD40L levels are regulated by the -3459 A. G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome. Arterioscler Thromb Vasc Biol 26, 1667-73 (2006).
33. Skibola, C. F. et al. A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood 111, 4348-54 (2008).
34. Chen, H. Y. et al. Functional Interaction Between SNPs and Microsatellite in the Transcriptional Regulation of Insulin-Like Growth Factor 1. Hum Mutat 34, 1289-97 (2013).
35. Chadha, S. et al. Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur J Hum Genet 13, 669-76 (2005).
36. Montpetit, A. et al. An evaluation of the performance of tag SNPs derived from HapMap in a Caucasian population. PLoS Genet 2, e27 (2006).
37. Ribas, G. et al. Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes. Hum Genet 118, 669-79 (2006).
38. Citores, M. J. et al. CD154 polymorphism in Spanish populations. Differences in the allelic distribution between Canary islanders and Peninsulars. Eur J Immunogenet 27, 141-4 (2000).
39. Gomolka, M. et al. Immunoprinting: various genes are associated with increased risk to develop rheumatoid arthritis in different groups of adult patients. J Mol Med (Berl) 73, 19-29 (1995).
40. DiSanto, J. P. et al. Brief report: prenatal diagnosis of X-linked hyper-IgM syndrome. N Engl J Med 330, 969-73 (1994).
41. Dmitrienko, S., Hoar, D. I., Balshaw, R. & Keown, P. A. Immune Response Gene Polymorphisms in Renal Transplant Recipients. Transplantation 80, 1773-1782 (2005).
42. Stewart, S., Wickramasinghe, D., Dorrance, A. E. & Robertson, A. E. Comparison of three microsatellite analysis methods for detecting genetic diversity in Phytophthora sojae (Stramenopila: Oomycete). Biotechnol Lett 33, 2217-23 (2011).
43. Citores, M. J. The dinucleotide repeat polymorphism in the 39UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus. Annals of the Rheumatic Diseases 63, 310-317 (2004).
44. Bugert, P. et al. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154. Thromb Haemost 97, 573-80 (2007).
45. Martin-Donaire, T. et al. Association of the microsatellite in the 39 untranslated region of the CD154 gene with rheumatoid arthritis in females from a Spanish cohort: a case-control study. Arthritis Res Ther 9, R89 (2007).
46. Bejaoui, M., Mellouli, F., Chouanine, R., Dellagi, K. & Barbouche, M. R. [The hyper-IgM syndrome: 13 observations]. Presse Med 32, 544-9 (2003).
47. Mirkin, S. M. Expandable DNA repeats and human disease. Nature 447, 932-40 (2007).
48. Hamilton, B. J. et al. Separate cis-trans pathways post-transcriptionally regulate murine CD154 (CD40 ligand) expression: a novel function for CA repeats in the 39-untranslated region. J Biol Chem 283, 25606-16 (2008).
49. Hui, J. et al. Intronic CA-repeat and CA-rich elements: a new class of regulators of mammalian alternative splicing. EMBO J 24, 1988-98 (2005).
50. Schubert, L. A. et al. A T cell-specific enhancer of the human CD40 ligand gene. J Biol Chem 277, 7386-95 (2002).
51. Fadhlaoui-Zid, K. et al. Sousse, Tunisia: tumultuous history and high Y-STR diversity. Electrophoresis 33, 3555-63 (2012).
52. Cherni, L. et al. Y-chromosomal STR haplotypes in three ethnic groups and one cosmopolitan population from Tunisia. Forensic Sci Int 152, 95-9 (2005).
53. Henn, B. M. et al. Genomic ancestry of North Africans supports back-to-Africa migrations. PLoS Genet 8, e1002397 (2012).
54. Andre, R. et al. International differences in acute coronary syndrome patients' baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study. Heart 100, 1201-7 (2014).
55. Saidi, O. et al. Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009. PLoS One 8, e63202 (2013).
56. Arnaud, L., Fagot, J. P., Paita, M., Fagot-Campagna, A. & Amoura, Z. Prevalence and incidence of systemic lupus erythematosus in France: A 2010 nation-wide population-based study. Autoimmun Rev (2014). doi:10.1016/j.autrev. 2014.08.034
57. Khanfir, M. S. et al. TULUP (TUnisian LUPus): a multicentric study of systemic lupus erythematosus in Tunisia. Int J Rheum Dis 16, 539-46 (2013).
58. Guillemin, F. et al. Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 64, 1427-30 (2005).
59. Maalej, A. et al. Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population. Scand J Rheumatol 37, 414-8 (2008).
60. Roulland, S. et al. t (14;18) Translocation: A predictive blood biomarker for follicular lymphoma. J Clin Oncol 32, 1347-55 (2014).
61. Grumbt, B., Eck, S. H., Hinrichsen, T. & Hirv, K. Diagnostic applications of next generation sequencing in immunogenetics and molecular oncology. Transfus Med Hemother 40, 196-206 (2013).
62. Lamia, S. et al. [Primary immunodeficiency disorders in 51 cases]. TunisMed 91, 38-43 (2013).
63. Choi, W. S., Jeon, O. H. & Kim, D. S. CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin alpha (IIb) beta (3). J Thromb Haemost 8, 1364-71 (2010).
64. Teruel, M. et al. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis. Arthritis Res Ther 14, R154 (2012).
65. Yu, B., Sawyer, N. A., Chiu, C., Oefner, P. J. & Underhill, P. A. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC). Curr Protoc Hum Genet Chapter 7, Unit7 10 (2006).
66. Fackenthal, D. L., Chen, P. X., Howe, T. & Das, S. Denaturing high-performance liquid chromatography for mutation detection and genotyping. Methods Mol Biol 1015, 25-54 (2013).
67. Fixman, M. & Freire, J. J. Theory of DNA melting curves. Biopolymers 16, 2693-704 (1977).